Didn't you mean to say that "things are falling apart just nicely?"
So, Mr. . . ."In The Know". . .what's up with JANX? I finally got my money back after riding this POS for so many years. . .listening to hucksters like you on message boards. Much has happened since that period in time. So what is it? Who has the "inside scoop" this time around. Are they finally going to begin selling something that was proclaimed to be so VERY CLOSE so many times in the past? Please advise.
Thanks.
So, Mr. . . ."In The Know". . .what's up with JANX? I finally got my money back after riding this POS for so many years. . .listening to hucksters like you on message boards. Much has happened since that period in time. So what is it? Who has the "inside scoop" this time around. Are they finally going to begin selling something that was proclaimed to be so VERY CLOSE so many times in the past? Please advise.
Thanks.
Recent JANX News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/28/2026 09:02:08 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/28/2026 08:56:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/28/2026 08:22:13 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/28/2026 08:15:41 PM
- Janux Therapeutics Announces Discontinuation of JANX008 Clinical Development • Business Wire • 04/27/2026 08:01:00 PM
- Janux Therapeutics Announces First Participant Dosed in Phase 1 Study of JANX014 • Business Wire • 04/16/2026 08:01:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/13/2026 08:05:35 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/02/2026 08:02:23 PM
- Janux secures $35 million milestone payment from Bristol Myers Squibb • IH Market News • 04/01/2026 02:01:33 PM
- Janux Therapeutics Announces Development Candidate Nomination Under Bristol Myers Squibb Collaboration, Triggering $35 Million Milestone Payment • Business Wire • 04/01/2026 12:01:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/26/2026 09:47:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2026 09:10:46 PM
- Janux Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights • Business Wire • 02/26/2026 09:01:00 PM
- Janux Therapeutics Announces First Patient Dosed in Phase 1 Study of JANX011 • Business Wire • 02/17/2026 12:00:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/06/2026 09:23:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2026 01:01:40 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2026 01:00:24 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/26/2026 09:20:12 PM
- Janux Therapeutics Appoints William Go, M.D., Ph.D., as Chief Medical Officer • Business Wire • 01/26/2026 12:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/23/2026 09:08:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2026 09:30:59 PM
- Janux Therapeutics jumps on new collaboration with Bristol Myers Squibb • IH Market News • 01/22/2026 01:39:50 PM
- Janux Therapeutics Announces Collaboration and Exclusive Worldwide License Agreement with Bristol Myers Squibb to Develop a Novel Tumor-Activated Therapeutic for Solid Tumors • Business Wire • 01/22/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2026 02:00:15 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2026 02:00:12 AM
